Current Issue - Volume 2 Issue 9 (September 2010)
- Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease
- Stephen J. McConoughey, Manuela Basso, Zoya V. Niatsetskaya, Sama F. Sleiman, Natalia A. Smirnova, Brett C. Langley, Lata Mahishi, Arthur J. L. Cooper, Marc A. Antonyak, Rick A. Cerione, Bo Li, Anatoly Starkov, Rajnish Kumar Chaturvedi, M. Flint Beal, Giovanni Coppola, Daniel H. Geschwind, Hoon Ryu, Li Xia, Siiri E. Iismaa, Judit Pallos, Ralf Pasternack, Martin Hils, Jing Fan, Lynn A. Raymond, J. Lawrence Marsh, Leslie M. Thompson, Rajiv R. Ratan
- Published online on Jul 21, 2010
- DOI: 10.1002/emmm.201000084 (p 349-370)
- Selective targeting of neuroblastoma tumour‐initiating cells by compounds identified in stem cell‐based small molecule screens
- Kristen M. Smith, Alessandro Datti, Mayumi Fujitani, Natalie Grinshtein, Libo Zhang, Olena Morozova, Kim M. Blakely, Susan A. Rotenberg, Loen M. Hansford, Freda D. Miller, Herman Yeger, Meredith S. Irwin, Jason Moffat, Marco A. Marra, Sylvain Baruchel, Jeffrey L. Wrana, David R. Kaplan
- Published online on Aug 18, 2010
- DOI: 10.1002/emmm.201000093 (p 371-384)
